Search research articles
Contact Us
Filters
Showing results (121-130 of 176) with videos related to
Page
of 18
Sort By:
Blood
|
June 24, 2021
CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma
Kai Rejeski, Ariel Perez, Pierre Sesques, et al.
Cancer Research
|
October 30, 2025
Multi-omics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery
Aleksandr Ianevski, Kristen Nader, Julia Nguyen, et al.
British Journal of Haematology
|
March 3, 2025
A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis
Pablo Mozas, Romain Ould Ammar, Loïc Chartier, et al.
Blood
|
April 24, 2024
Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma
Gilles Crochet, Gloria Iacoboni, Audrey Couturier, et al.
Clinical Nuclear Medicine
|
June 11, 2021
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells
Pierre Sesques, Jérémie Tordo, Emmanuelle Ferrant, et al.
British Journal of Haematology
|
July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO
Irit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
Blood
|
November 24, 2021
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma
Takashi Ishio, Sarvesh Kumar, Joji Shimono, et al.
Blood Advances
|
January 26, 2021
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma
François Lemonnier, Violaine Safar, Asma Beldi-Ferchiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2021
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
Emmanuel Bachy, Vincent Camus, Catherine Thieblemont, et al.
Hemasphere
|
February 19, 2025
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry
Jean Galtier, Charles Mesguich, Pierre Sesques, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 176) with videos related to
Sort By:
Page
of 18
Blood
|
June 24, 2021
CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma
Kai Rejeski, Ariel Perez, Pierre Sesques, et al.
Cancer Research
|
October 30, 2025
Multi-omics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery
Aleksandr Ianevski, Kristen Nader, Julia Nguyen, et al.
British Journal of Haematology
|
March 3, 2025
A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis
Pablo Mozas, Romain Ould Ammar, Loïc Chartier, et al.
Blood
|
April 24, 2024
Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma
Gilles Crochet, Gloria Iacoboni, Audrey Couturier, et al.
Clinical Nuclear Medicine
|
June 11, 2021
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells
Pierre Sesques, Jérémie Tordo, Emmanuelle Ferrant, et al.
British Journal of Haematology
|
July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO
Irit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
Blood
|
November 24, 2021
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma
Takashi Ishio, Sarvesh Kumar, Joji Shimono, et al.
Blood Advances
|
January 26, 2021
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma
François Lemonnier, Violaine Safar, Asma Beldi-Ferchiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2021
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
Emmanuel Bachy, Vincent Camus, Catherine Thieblemont, et al.
Hemasphere
|
February 19, 2025
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry
Jean Galtier, Charles Mesguich, Pierre Sesques, et al.
Page
of 18